Enrico Domenici

Enrico Domenici is an Associate Professor at the Department of Cellular, Computational, and Integrative Biology (CIBIO), University of Trento. He holds a PhD in Molecular Sciences/Chemistry from Scuola Normale Superiore, University of Pisa (1986–1990), and a Laurea in Biological Sciences from the University of Pisa (1980–1984). His research focuses on genomic and proteomic biomarkers in neuroscience, particularly schizophrenia, autism, and neurodegenerative disorders. He has led projects in drug discovery, functional genomics, and translational medicine, including roles at Roche and GSK. He coordinates international consortia such as the FP7 IN-SENS and CommonMind Consortium. His work integrates high-throughput genomic and proteomic data to identify therapeutic targets and biomarkers.

Key collaborations include partnerships with institutions like the Max Planck Institute of Psychiatry and the University of Helsinki, focusing on depression, stem cell research, and biomarker discovery. He has secured major grants, including the EU-funded GENDEP project (€7.5M) and the IN-SENS initiative (€3.9M). His research spans preclinical to clinical stages, emphasizing systems biology approaches and multi-omics integration. He advises on psychiatric genetics and serves on editorial boards for journals like Molecular Psychiatry and Neuropsychopharmacology.

His scientific contributions include identifying biomarkers for depression and schizophrenia, analyzing genetic risk variants in autism, and modeling disease mechanisms in neurodegenerative disorders. He has supervised numerous students and fosters translational research through academia-industry partnerships. Current efforts emphasize leveraging omics data for precision medicine in neuropsychiatric disorders.